Published:
Last updated:
conform nederlandse tekst
ID
NL-OMON36752
Source
ToetsingOnline
Brief title
SELECT-AMI
Condition
- Heart failures
- Cardiac therapeutic procedures
Synonym
heart failure, ischemic cardiomyopathy
Research involving
Human
Sponsors and support
Primary sponsor
:
Cardiovascular Center Aalst
Source(s) of monetary or material Support
:
wetenschapsgeld deelnemende ziekenhuizen,Miltenyi Biotec
Intervention
Keyword
:
Coronary, Myocardial infarction, Stemcell, Transplantation
Outcome measures
Primary outcome
conform nederlandse tekst
Secondary outcome
conform nederlandse tekst
Background summary
conform nederlandse tekst
Study objective
conform nederlandse tekst
Study design
conform nederlandse tekst
Intervention
conform nederlandse tekst
Study burden and risks
conform nederlandse tekst
Public
Cardiovascular Center Aalst
Moorselbaan 164
9300 Aalst
Belgie
Moorselbaan 164
9300 Aalst
Belgie
Scientific
Cardiovascular Center Aalst
Moorselbaan 164
9300 Aalst
Belgie
Moorselbaan 164
9300 Aalst
Belgie
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
conform nederlandse tekst
Exclusion criteria
conform nederlandse tekst
Design
Study phase
:
2
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Double blinded (masking used)
Control
:
Placebo
Primary purpose
:
Treatment
Recruitment
NL
Recruitment status
:
Will not start
Enrollment
:
30
Type
:
Anticipated
Medical products/devices used
Product type
:
Medicine
Generic name
:
Somatic cells autologous
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
CCMO: Centrale Commissie Mensgebonden Onderzoek (Den Haag)
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2007-001448-33-NL |
CCMO | NL35051.000.10 |